Elizabeth Rocco, MD
Internal Medicine · Yorktown Heights, NYNPI 1922174077
Payments from drug & device makers
Across 120 payments — averaging $24.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$462
- Boehringer Ingelheim$356
- Exact Sciences$217
- Novo Nordisk$210
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$188
- Lundbeck LLC$178
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,919100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 19 | $462 |
| Boehringer Ingelheim | 13 | $356 |
| Exact Sciences | 5 | $217 |
| Novo Nordisk | 11 | $210 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $188 |
| Lundbeck LLC | 8 | $178 |
| Bristol Myers Squibb | 3 | $140 |
| Pfizer | 6 | $123 |
| Amgen | 5 | $123 |
| GSK | 5 | $110 |
| Lilly USA, LLC | 5 | $106 |
| Gilead | 1 | $104 |
| AstraZeneca | 5 | $87 |
| Otsuka America Pharmaceutical, Inc. | 4 | $82 |
| Ardelyx, Inc. | 2 | $57 |
| Bayer | 2 | $39 |
| Electromed, Inc. | 2 | $37 |
| Nestle Healthcare Nutrition Inc. | 2 | $35 |
| Scpharmaceuticals Inc. | 2 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Almatica Pharma LLC | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Medtronic | 1 | $19 |
| Baxter Healthcare | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Redhill Biopharma Inc. | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Otezla$125
- JARDIANCE$125
- Cologuard Collection Kit$123
- Epclusa$104
How this compares
$2,919 in reported general payments places this provider in the 80th percentile of 9,771 internal medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 45 | $56,394 |
| EliquisApixaban | 45 | $50,890 |
| JardianceEmpagliflozin | 34 | $35,957 |
| MounjaroTirzepatide | 19 | $19,654 |
| JanuviaSitagliptin Phosphate | 12 | $12,749 |
| LinzessLinaclotide | 14 | $8,073 |
| MyrbetriqMirabegron | 16 | $7,455 |
| SymbicortBudesonide/Formoterol Fumarate | 16 | $5,977 |
| NexiumEsomeprazole Magnesium | 11 | $2,734 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 55 | $1,993 |
| Rosuvastatin Calcium | 133 | $1,569 |
| Metoprolol Succinate | 108 | $1,298 |
| FenofibrateFenofibrate Nanocrystallized | 61 | $1,117 |
| Atorvastatin Calcium | 161 | $1,075 |
| Celecoxib | 27 | $1,016 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $210 | $56,39445 claims |
| PfizerEliquis | $123 | $50,89045 claims |
| Boehringer IngelheimJardiance | $356 | $35,95734 claims |
| Lilly USA, LLCMounjaro | $106 | $19,65419 claims |
| AstraZenecaSymbicort, Nexium | $87 | $8,71127 claims |
| AbbVieLinzess | $462 | $8,07314 claims |
| Almatica Pharma LLCSertraline Hcl | $28 | $20238 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Yorktown Heights
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
- Patrick ReaganRochester$9.4M
- Sally LauNew York$8.4M
- Angela BrancheRochester$7.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.